View
646
Download
1
Tags:
Embed Size (px)
DESCRIPTION
Healthcare organizations today are seeking commercial effectiveness as a source of competitive advantage especially in light of current day challenges – patent loss, cost pressures, new product approval processes, and emerging new influencers to name a few. Towards this end, organizations are using Social Media as a marketing, communication and engagement tool. Common outcomes and measures include Facebook likes, Twitter followers, increased awareness, and share of voice. But, can Social Media impact revenues? Is this even a realistic expectation? Debjani Deb,Managing Partner, EmPower Research and Buddy Scalera,SVP - Interactive Content & Market Research, Ogilvy CommonHealth Worldwide, two distinguished thought-leaders, share their perspectives on how Social Media can enable stakeholder insights and impact revenues.
Citation preview
© 2011 Copyright Genpact. All Rights Reserved
Social Media and Revenue Impact
I s i t an un rea l i s t i c expec ta t ion?
THE CHANGING LANDSCAPE SEC T I O N 1
The paradigm shift we see today : pharma’s traditional models
are at risk
Innovation and R&D gap is shrinking
rapidly leading to lesser and lesser
differentiation
You Competitors
$ 83 Billion
2009
$ 150 Billion+
2015
Fierce price competition due to growing
market for generics is resulting in
slashed profit margins
Shrinking innovation gap Rise of the generics
Ge
ne
rics m
ark
et s
ize
pro
jectio
n
In
no
va
tio
n a
nd
R
&D
Source: BCC Research
The competitive environment today is fueling the race to attract
stakeholders
The race is on to win over stakeholders
1
How can we create enough positive awareness,
perception and sentiment among stakeholders to
drive active consideration for our brands?
2
How can we channelize positive stakeholder
experiences to drive advocacy and at the same time
avoid viral negativity of bad experiences?
3
How can we learn from stakeholders to identify
emerging trends, unmet needs, issues and
opportunities across the disease life-cycle?
The advent of social media as a potential game changer: the
trend coincides with the needs that marketers face
83%
of online adults search
for health information
look up a specific
disease or problem
66%
Seek alternative
treatments
35%
Search for “someone
like me” experience
60%
6 out of 10
Doctors in US are online
Sources: The Social Life of Health Information, Pew Internet and American Life Project, Forrester Research, Manhattan Research
of Pharma companies use social media
66% 50%
of online physicians refer Wikipedia
21%
of physicians use Social Media to connect to KOLs
FACEBOOK TWITTER GOOGLE BUZZ YOU TUBE BLOGGER
STUMBLE UPON LINKED IN PICASA MYSPACE FLICKR
AUDIENCE
DISCUSSION:
How many of you are currently
engaged in some form
ADAPTING TO THE CHANGE SEC T I O N 2
Market
Listen
Learn
Engage
Regulatory Bodies
The evolution of social media adoption
The listen, learn, engage cycle has applications across the
disease lifecycle
Lifestyle Treatment Diagnosis Pre-diagnosis
• Understand information
flow and online support
sought by stakeholders
• Learn how this flow
varies by therapeutic
area
• Learn about points of
influence and the
influence map
• Know more about
patient pathways to
facilitate early
diagnosis
• Learn about
medication adherence
trends for a disease
• Understand why
certain drug brands
are being considered
over others
• Learn about the
health and wellness
associations to
design holistic
wellness
management
program
Online KOL identification and tracking at each stage
APPLICATIONS OF SOCIAL MEDIA C ASE ST U D I E S AC R O S S D I SE A S E L I F EC Y C L E
A major drug company
used social media to
understand search
patterns for allergic
asthma.
This helped them
develop optimal
information messaging
strategy.
Asthma attack
Breathing problems
asthma symptoms treatment
asthma diabetes Asthma
Allergic
Asthma
Severe
Allergic
Asthma
Bronchitis symptoms
Shortness of breath
allergy asthma
associates
allergy asthma center
Skin asthma
Cat asthma
allergy asthma associates
COPD repeated attacks
Difficult breathing
ventolin
high IgE
A i l l u s t r a t i v e a p p l i c a t i o n f o r t h e p r e - d i a g n o s i s p h a s e :
L e a r n i n g a b o u t i n f o r m a t i o n f l o w
Lack of knowledge
amongst physicians and
late emergence of
symptoms for Acromegaly
leading to late diagnosis
were key concerns.
Social Media Analysis
helped in understanding
the patient journey from
symptom to treatment.
A i l l u s t r a t i v e a p p l i c a t i o n f o r t h e d i a g n o s i s p h a s e :
M a p p i n g p a t i e n t p a t h w a ys
Minor/ Early Symptoms leading to Acromegaly
General PhysicianPeer Suggestion/ Online
Treatment for the minor ailments
Patient Still Suffering
Physical deformation
Endocrinologist Neurologist Other Specialists (Lack of evidence of
activities)
Diagnosis (GH, IGF) Brain MRI Scan
Confirms Acromegaly Treatment
Surgery (large tumor) Medication (small tumor)
Radiation (for residues) Acromegaly Treated
Diagnosis (30%)
Treatment (36%)
Recurrence
Acromegaly Cured
Reoccurrence/ Cured (11%)
Symptoms (51%)
Ea
rly S
ym
pto
ms
La
te
Sy
mp
to
ms
A global Pharma leader
uses social media to
identify online influencers
and track their influence
sphere for Atrial fibrillation.
It uses this information to
learn how online
influencers are shaping
treatment choices
A i l l u s t r a t i v e a p p l i c a t i o n f o r t h e d i a g n o s i s p h a s e :
I d e n t i f y i n g p o i n t s o f i n f l u e n c e
Blogs
Other
KOLs
Influencer
Site
Mass Social
Media(Facebook,
You Tube,
LinkedIn…)
Blogs
Blogs
Independent
Communities
Regulators
Advocacy
Groups
Local
UserGroups
Discussion
Groups
Community
Portal
Most physicians
considered Drug X very
efficacious.
However, social media
research revealed that
patients want to switch
to more economical
alternatives.
A i l l u s t r a t i v e a p p l i c a t i o n f o r t h e t r e a t m e n t p h a s e :
Tr a c k i n g b r a n d K P I s
Switchers
Loyalists
Prospects
What Patients Felt
0
10
20
30
40
50
60
70
Theme 5 Theme 4 Theme 3 Theme 2 Efficacy
0
10
20
30
40
50
60
70
Price Theme 2 Theme 3 Theme 4 Theme 5
What Physicians Said
A i l l u s t r a t i v e a p p l i c a t i o n f o r t h e t r e a t m e n t p h a s e :
Tr a c k i n g a d h e r e n c e a n d i t ’ s d r i v e r s
While Afinitor’s
prescribed dosage is
10mg, Social media
research revealed that
many patients preferred
5mg dosage owing to
adverse reactions
Personal
Factors
Emotional state
Health beliefs
Socio Economic
Factors
Interaction
with System
Relationship with
providers
Satisfaction with care
Side effects
Costs
Immediate benefits
Treatment
Factors
Factors
impacting
adherence
A i l l u s t r a t i v e a p p l i c a t i o n f o r t h e l i f e s t y l e p h a s e :
I d e n t i f y i n g a s s o c i a t i o n s o f h e a t h a n d w e l l n e s s
Association 1
Sub-themes
Association 2
Association 3
Association 4
Association 5
Sub-themes
Sub-themes
Sub-themes
Sub-themes
Sub-themes Sub-themes
Sub-themes
Sub-themes Sub-themes
Sub-themes
Sub-themes
Sub-themes
Sub-themes
A leading CPG firm
used social media to
understand the
emerging associations
of health and wellness
and identify
opportunities for
messaging and
education.
SOCIAL MEDIA RoI
SEC T I O N 3
Metrics need to reflect
impact on top line or
bottom line
Leadership will not be content when
results are conveyed as re-tweets,
fans or number of followers
R e le v a n c e Management is not convinced by
absolute measure such as these
DASHBOARDS
SITE STATISTICS
Its all good to listen, learn and engage but the core issue
today is to be able to measure returns
Clearly, the market is moving towards listen, learn, engage with
a RoI intention
Market Listen Learn Engage
Monitor
Chatter
Adherence
Levels
Perception
Mapping
Brand
Sentiments
Patient
Pathways
Influencer
Mapping
Crowd
Sourcing
Bottom line
reduction
Top line
enhancement Event
Efficacy
Social
Media
Presence
Segmentation
Untapped
Opportunities
Crisis
Alerts
EXAMPLES OF RoI C ASE ST U D I E S
Therefore Revenue loss due to switchers
= 1600* $42,300 ≈ $ 67.6 Million
C a s e
b a c k g r o u n d
Copaxone, used for treating Multiple Sclerosis was analyzed
in social media to understand brand consideration and
losses due to switching behavior
Case 1: stemming revenue leakage
N o t e : There were more than 20,000 conversations on the brand of which 6156 pertained to purchase consideration
Therefore Revenue opportunity in Pre-diagnosis
= 563* $30,000 ≈ $ 17 Million
C a s e
b a c k g r o u n d
Social media conversations on pre-diagnosis for Acromegaly
were analyzed to gauge business potential for early online
engagement with patients
Case 2: smart targeting
Lifestyle
Treatment
Diagnosis
Pre-
diagnosis
Educating these
patients about their
condition will help in
gravitating them
towards an early and
timely treatment
phase, and thus help in
revenue optimization
N o t e : There were 10,116 conversations on Acromegaly of which 971 were identified to have originated by unique patients
Revenue opportunity by driving adherence
(3354 +0.5*2236)*$1392 ≈ $ 6.2 Million
C a s e
b a c k g r o u n d
Conversations on Crestor were analyzed to estimate the
potential revenue opportunity if adherence issues can be
identified in time and acted upon
Case 3: driving adherence
N o t e : 8.5 % of all conversations were found to be on medication adherence
Revenue opportunity by driving advocacy
2,316 * $70 ≈ $ 162,000
C a s e
b a c k g r o u n d
Metamucil , a major OTC brand in laxatives category was
tracked to gauge revenue impact potential that brand
advocates and influencers can generate
Case 4: driving advocacy
N o t e : Our research shows that each advocate (people recommending the drug) can influence 3 patients on an average
DISCUSSION: BEST PRACTICES SEC T I O N 4
26
LEGAL
PUBLIC RELATIONS
MARKETING
BRAND TEAMS
COUNTRY SPECIFIC TEAMS
R & D
How can I use this
medium to monitor and
act on negativity?
What are the AE
implications?
How can we enable
engagement with
stakeholders?
Will the methodology
hold up?
How does it provide
insights over and above
existing trackers?
Can I get local market
insights?
w w w . g e n p a c t . c o m
Thank You !
w w w . e m p o w e r r e s e a r c h . c o m
© 2011 Copyright Genpact. All Rights Reserved
Social Media
in
Pharmaceutical Commercial Context
Buddy Scalera SVP - Interactive Content
& Market Research
Ogilvy CommonHealth Worldwide
Hi.
@MarketingBuddy
What are social networks
• Social networks are groups of individuals
unified by common
• Interests
• Vocations
• Passions
• Needs
• Before the Internet groups were limited
by proximity
• Online social networks are all about the
Long Tail context
• Fans of Walking Dead
• Moms who marathon
• Vampires in New York
Context & Proximity Motivates people to take action because it is relevant.
And It Isn’t New in Pharma
KOL 1.0 KOL 2.0 – the Virtual Community Leaders
Traditional
• Academia
• Department Chairs
• Research/ Clinical Trial Investigator
• Published
Extended
• Global Recognition
• Regional (US, EMEA, LatAM, Asia)
• Local
AHCP
• Nurses
• Nurse Practitioners
• Physician Assistants
• Pharmacists
• Dieticians
• OT
Managed Markets
• HECON
• P&T Committee
• Formulary
• Medical Ad Board
• Megaplans
Dr. Digital
• HCP Blogs
• SERMO
• Social Networks
• Satellite Radio
• TV
• Web sites
• Podcasters
Consumer/ Digital
• Bloggers
• Social networks
• Bulletin Boards
• Chat Rooms
• Advocacy sites
• E-zines
• Websites
33
Not necessarily.
Pharma Started Getting Social on MySpace
Pharma on Facebook
Pharma on YouTube & Podcasts
Pharma Blogs & Tweets
Professional
A Conundrum
• How can we participate in social & Web 2.0 marketing….while being responsible to our
brands?
Some Things Are In Our Control
• Fresh, factual content is welcome… share it
• Lack of content limits our voice and damages our credibility…speak up
• Reputation and respect must be earned, cultivated, and maintained…
step up
Some Things Are Not…
• Brand bashers
• Modern-day mashups
• The next big thing…
Where Do We Go From Here?
• Use our voices…silence is not golden
• Promote our product benefits…
• Engage where we can…
Avoid Direct Mail from the FDA
• FDA Guidelines
• AE Challenges
Investing in Social
• Setting KPIs
• Driving Conversions
• Measure ROI
46
Be Authentic
• Trust Marketing & Reputation Marketing are more important than ever
• You can fool some of the people…but you’ll probably get caught
New Opportunities
• Innovators and early adopters have laid a solid foundation
• Evolving technology is developing a brave new world…in real time
• Social media marketing is slow
Be the Best 2nd.
49
3 Rules for 2.0
• Speak the Language
• Keep it Real
• Measure, Modify, Move
Thank you!
Let’s be friends.
See you at DTC National 2012!
973-352-4180
Ogilvy CommonHealth Worldwide: blog.ogilvychww.com
Buddy’s Marketing Blog: WordsPicturesWeb.com
Twitter @MarketingBuddy